Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

$ABBVPress releaseJul 14, 2026, 8:05 AM ETRead the release

Allergan Aesthetics, an AbbVie company, is expanding its SkinMedica R&D facility in Irvine, California, more than doubling its footprint to support next-generation skincare research and AI-enabled ingredient discovery. The brand also launched a Regenerative Science Advisory Board composed of leading physicians to foster clinical dialogue and bridge research with everyday patient care.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.